Skip to main content

PRELUDE CAPITAL MANAGEMENT, LLC

Position in CRON — Cronos Group Inc.

CIK 1387508 NEW YORK, NY

Position in CRON

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$3,765,000
+$2,229,793 QoQ
Shares Held
1,500,000
+157.0% QoQ
Ownership
0.401%
of shares outstanding
% of Portfolio
0.31%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2020
12 quarters on record
Voting authority Sole 0% Shared 100% None 0%

Common Shares in CRON Over Time

Shares Held

Position Value (USD)

Derivatives in CRON

reported options exposure · as of Sep 30, 2020
CallValue
$28,557
CallShares
5,700
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Mar 31, 2026

PRELUDE CAPITAL MANAGEMENT, LLC holds $21,122,108 across 18 Drug Manufacturers - Specialty & Generic names. CRON ranks #3 (17.8% of the industry book) .

# Ticker Company Shares Value (USD) Open
3 CRON
Cronos Group Inc.
This page
1,500,000 $3,765,000

All Filings in CRON

Export CSV
13 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $3,765,000 1,500,000
2025-12-31 $1,535,207 583,729
2025-09-30 $2,209,321 794,720
2025-06-30 $2,592,464 1,357,311
2025-03-31 $3,204,983 1,770,709
2024-12-31 $450,498 223,019
2024-09-30 $77,252 35,275
2024-06-30 $82,190 35,275
2024-03-31 $36,975 14,167
2020-09-30 $28,557 5,700
2020-06-30 $7,212 1,200
2020-03-31 $1,134 200
2020-03-31 $9,072 1,600